Skip to content

Clinical trials

Phase 3 Hypertension trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 3 Country / region: Argentina Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20067
20073
20085
20091
20101
20132
20141
20151
20181
20193
20221
20231
20243
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated7
Active, not recruiting4
Recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Boehringer Ingelheim4
Gilead Sciences4
Takeda4
Eli Lilly and Company3
Novartis3
Novartis Pharmaceuticals3
GlaxoSmithKline2
United Therapeutics2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension38
Cardiovascular Diseases9
Essential Hypertension5
Diabetes Mellitus, Type 23
Pulmonary Arterial Hypertension3
Renal Insufficiency, Chronic3
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Heart Failure2
Hypertension, Pulmonary2

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.